This report describes and explains the POC HbA1C testing market and covers 2018-2023, termed the historic period, and 2023-2028, 2033F termed the forecast period. The report evaluates the market across each region and for the major economies within each region.
The global POC HbA1C testing market reached a value of nearly $842.91 million in 2023, having grown at a compound annual growth rate (CAGR) of 7.77% since 2018. The market is expected to grow from $842.91 million in 2023 to $1.44 billion in 2028 at a rate of 11.45%. The market is then expected to grow at a CAGR of 10.96% from 2028 and reach $2.43 billion in 2033.
Growth in the historic period resulted from an increase in disposable income, rising adoption of personalized medicine and healthcare infrastructure improvements. Factors that negatively affected growth in the historic period were the development of alternative blood monitoring methods.
Going forward, rising prevalence of diabetes, expanding geriatric population, strong economic growth in emerging markets, rise in government support and regulatory support and reimbursement policies will drive the growth. Factor that could hinder the growth of the POC HbA1C testing market in the future include lack of trained healthcare professionals.
The POC HbA1C testing market is segmented by type of product into instruments and consumables. The consumables market was the largest segment of the POC HbA1C testing market segmented by type of product, accounting for 58.2% or $490.65 million of the total in 2023. Going forward, the consumables segment is expected to be the fastest growing segment in the POC HbA1C testing market segmented by type of product, at a CAGR of 12.23% during 2023-2028.
The POC HbA1C testing market is segmented by technology into ion-exchange HPLC, enzymatic assay affinity binding and immunoassay. The immunoassay market was the largest segment of the POC HbA1C testing market segmented by technology, accounting for 35.8% or $301.37 million of the total in 2023. Going forward, the immunoassay segment is expected to be the fastest growing segment in the POC HbA1C testing market segmented by technology, at a CAGR of 12.53% during 2023-2028.
The POC HbA1C testing market is segmented by end user into hospitals, physician office/outpatient center, home care and other end users. The hospitals market was the largest segment of the POC HbA1C testing market segmented by end user, accounting for 42.8% or $361.06 million of the total in 2023. Going forward, the home care segment is expected to be the fastest growing segment in the POC HbA1C testing market segmented by end user, at a CAGR of 13.76% during 2023-2028.
North America was the largest region in the POC HbA1C testing market, accounting for 37% or $312.23 million of the total in 2023. It was followed by Asia-Pacific, Western Europe and then the other regions. Going forward, the fastest-growing regions in the POC HbA1C testing market will be North America and Western Europe where growth will be at CAGRs of 12.76% and 11.62% respectively. These will be followed by Asia-Pacific and South America where the markets are expected to grow at CAGRs of 10.40% and 10.08% respectively.
The global POC HbA1C testing market is highly concentrated, with large players operating in the market. The top ten competitors in the market made up 81.2% of the total market in 2023. Siemens Healthineers AG was the largest competitor with a 17.5% share of the market, followed by F. Hoffmann-La Roche AG with 12.9%, Bio-Rad Laboratories, Inc. with 12.4%, Menarini Group with 11.3%, Danaher Corporation with 9.1%, i-SENS, Inc. with 5.7%, Tosoh Corp. with 5%, ARKRAY Inc. with 4.4%, Abbott Laboratories with 2% and LumoraDX with 0.9%.
The top opportunities in the POC HbA1C testing market segmented by type of product will arise in the consumables segment, which will gain $383.02 million of global annual sales by 2028. The top opportunities in the POC HbA1C testing market segmented by technology will arise in the immunoassay segment, which will gain $242.52 million of global annual sales by 2028. The top opportunities in the POC HbA1C testing market segmented by end user will arise in the physician office/outpatient center segment, which will gain $244.9 million of global annual sales by 2028The POC HbA1C testing market size will gain the most in the USA at $223.89 million.
Market-trend-based strategies for the POC HbA1C testing market include focus on advanced point-of-care solution for rapid and accurate HbA1C testing, launch of next-generation point-of-care device enhances diabetes management and early diagnosis, FDA approval for innovative point-of-care HbA1C testing system using menstrual blood and strategic partnerships and acquisition among major players to enhance product offerings.
Player-adopted strategies in the POC HbA1C testing market include focuses on strengthening its business operations through strategic partnerships and new product launches to expand their business expertise.
To take advantage of the opportunities, the analyst recommends the POC HbA1C testing companies to focus on enhancing multi-parameter testing solutions, focus on enhancing efficiency and adoption of advanced POC devices, focus on product innovation and patient convenience, focus on consumables market growth for POC hba1c testing companies, focus on immunoassay market growth for POC hba1c testing companies, expand in emerging markets, focus on expanding distribution channels through strategic partnerships, focus on pricing strategies to enhance competitive positioning, focus on targeted marketing to healthcare providers, focus on digital channels and patient awareness and focus on hospitals to enhance adoption of POC hba1c testing.
The global POC HbA1C testing market reached a value of nearly $842.91 million in 2023, having grown at a compound annual growth rate (CAGR) of 7.77% since 2018. The market is expected to grow from $842.91 million in 2023 to $1.44 billion in 2028 at a rate of 11.45%. The market is then expected to grow at a CAGR of 10.96% from 2028 and reach $2.43 billion in 2033.
Growth in the historic period resulted from an increase in disposable income, rising adoption of personalized medicine and healthcare infrastructure improvements. Factors that negatively affected growth in the historic period were the development of alternative blood monitoring methods.
Going forward, rising prevalence of diabetes, expanding geriatric population, strong economic growth in emerging markets, rise in government support and regulatory support and reimbursement policies will drive the growth. Factor that could hinder the growth of the POC HbA1C testing market in the future include lack of trained healthcare professionals.
The POC HbA1C testing market is segmented by type of product into instruments and consumables. The consumables market was the largest segment of the POC HbA1C testing market segmented by type of product, accounting for 58.2% or $490.65 million of the total in 2023. Going forward, the consumables segment is expected to be the fastest growing segment in the POC HbA1C testing market segmented by type of product, at a CAGR of 12.23% during 2023-2028.
The POC HbA1C testing market is segmented by technology into ion-exchange HPLC, enzymatic assay affinity binding and immunoassay. The immunoassay market was the largest segment of the POC HbA1C testing market segmented by technology, accounting for 35.8% or $301.37 million of the total in 2023. Going forward, the immunoassay segment is expected to be the fastest growing segment in the POC HbA1C testing market segmented by technology, at a CAGR of 12.53% during 2023-2028.
The POC HbA1C testing market is segmented by end user into hospitals, physician office/outpatient center, home care and other end users. The hospitals market was the largest segment of the POC HbA1C testing market segmented by end user, accounting for 42.8% or $361.06 million of the total in 2023. Going forward, the home care segment is expected to be the fastest growing segment in the POC HbA1C testing market segmented by end user, at a CAGR of 13.76% during 2023-2028.
North America was the largest region in the POC HbA1C testing market, accounting for 37% or $312.23 million of the total in 2023. It was followed by Asia-Pacific, Western Europe and then the other regions. Going forward, the fastest-growing regions in the POC HbA1C testing market will be North America and Western Europe where growth will be at CAGRs of 12.76% and 11.62% respectively. These will be followed by Asia-Pacific and South America where the markets are expected to grow at CAGRs of 10.40% and 10.08% respectively.
The global POC HbA1C testing market is highly concentrated, with large players operating in the market. The top ten competitors in the market made up 81.2% of the total market in 2023. Siemens Healthineers AG was the largest competitor with a 17.5% share of the market, followed by F. Hoffmann-La Roche AG with 12.9%, Bio-Rad Laboratories, Inc. with 12.4%, Menarini Group with 11.3%, Danaher Corporation with 9.1%, i-SENS, Inc. with 5.7%, Tosoh Corp. with 5%, ARKRAY Inc. with 4.4%, Abbott Laboratories with 2% and LumoraDX with 0.9%.
The top opportunities in the POC HbA1C testing market segmented by type of product will arise in the consumables segment, which will gain $383.02 million of global annual sales by 2028. The top opportunities in the POC HbA1C testing market segmented by technology will arise in the immunoassay segment, which will gain $242.52 million of global annual sales by 2028. The top opportunities in the POC HbA1C testing market segmented by end user will arise in the physician office/outpatient center segment, which will gain $244.9 million of global annual sales by 2028The POC HbA1C testing market size will gain the most in the USA at $223.89 million.
Market-trend-based strategies for the POC HbA1C testing market include focus on advanced point-of-care solution for rapid and accurate HbA1C testing, launch of next-generation point-of-care device enhances diabetes management and early diagnosis, FDA approval for innovative point-of-care HbA1C testing system using menstrual blood and strategic partnerships and acquisition among major players to enhance product offerings.
Player-adopted strategies in the POC HbA1C testing market include focuses on strengthening its business operations through strategic partnerships and new product launches to expand their business expertise.
To take advantage of the opportunities, the analyst recommends the POC HbA1C testing companies to focus on enhancing multi-parameter testing solutions, focus on enhancing efficiency and adoption of advanced POC devices, focus on product innovation and patient convenience, focus on consumables market growth for POC hba1c testing companies, focus on immunoassay market growth for POC hba1c testing companies, expand in emerging markets, focus on expanding distribution channels through strategic partnerships, focus on pricing strategies to enhance competitive positioning, focus on targeted marketing to healthcare providers, focus on digital channels and patient awareness and focus on hospitals to enhance adoption of POC hba1c testing.
Table of Contents
1. Executive Summary
6. Market Characteristics
7. Major Market Trends
8. POC HbA1C Testing Market - Macro-Economic Scenario
9. Global Market Size and Growth
10. Global POC HbA1C Testing Market Segmentation
11. POC HbA1C Testing Market, Regional and Country Analysis
12. Asia-Pacific Market
13. Western Europe Market
14. Eastern Europe Market
15. North America Market
16. South America Market
17. Middle East Market
18. Africa Market
19. Competitive Landscape and Company Profiles
20. Other Major and Innovative Companies
23. Key Mergers and Acquisitions
24. Opportunities and Strategies
25. POC HbA1C Testing Market, Conclusions and Recommendations
26. Appendix
Executive Summary
POC HbA1c Testing Global Market Opportunities And Strategies To 2032 provides the strategists; marketers and senior management with the critical information they need to assess the global POC HbA1c testing market as it emerges from the COVID-19 shut down.Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 12 geographies.
- Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market research findings.
- Benchmark performance against key competitors.
- Utilize the relationships between key data sets for superior strategizing.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Description:
Where is the largest and fastest-growing market for POC HbA1c testing? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The POC HbA1c testing market global report answers all these questions and many more.The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market’s history and forecasts market growth by geography. It places the market within the context of the wider POC HbA1c testing market; and compares it with other markets.
The report covers the following chapters
- Introduction and Market Characteristics
- Key Trends
- Global Market Size and Growth
- Regional Analysis
- Market Segmentation
- Regional Market Size and Growth
- Competitive Landscape
- Key Mergers and Acquisitions
- Market Opportunities And Strategies
- Conclusions And Recommendations
- Appendix
Scope
Markets Covered:
1) By Type Of Product: Instruments; Consumables2) By Technology: Ion-Exchange HPLC; Enzymatic Assay; Affinity Binding Chromatography; Immunoassay; Other Technologies
3) By End User: Hospitals; Physician Office/Outpatient Center; Home Care; Other End Users
Companies Mentioned: F. Hoffmann-La Roche Ltd; Siemens Healthineers AG; Bio-Rad Laboratories, Inc; Menarini Group; Danaher Corporation
Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Brazil; France; Germany; UK; Russia
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time-series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; POC HbA1c testing indicators comparison.
Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Companies Mentioned
- Siemens Healthineers AG
- F. Hoffmann-La Roche AG
- Bio-Rad Laboratories, Inc.
- Menarini Group
- Danaher Corporation
- i-SENS, Inc.
- Tosoh Corp.
- ARKRAY Inc.
- Abbott Laboratories
- LumoraDX
- Roche Diagnostics
- Hipro Biotechnology
- Osang HealthCare Co Ltd.
- PTS Diagnostics
- bioMérieux
- Rapid Diagnostic Pvt. Ltd.
- CPC Diagnostics Pvt. Ltd.
- Agappe Diagnostic Ltd.
- Transasia Bio-Medicals Ltd.
- Nipro Corp
- Sekisui Medical Co. Ltd.
- HemoCue AB
- Achira Labs Pvt. Ltd.
- AccuBioTech Co., Ltd.
- Molbio Diagnostics Pvt. Ltd.
- Getein Biotech
- SugenTech Inc.
- Trinity Biotech plc.
- EKF Diagnostics
- A.Menarini Diagnostics Ltd.
- DiaSys Diagnostic Systems GmbH
- Novo Nordisk
- QIAGEN N.V.
- Curiosity Diagnostics
- Switch Health
- Qvin
- ACON Laboratories
- Precision Diabetes Inc.
- Echo Therapeutics, Inc.
- LifeLabs
- Quidel Corporation
- Nova Biomedical
- Diazyme Laboratories
- Alere
- Grupo Biolab
- AstraZeneca
- Ortho Clinical Diagnostics
- Tamer
- BioTeknica
- Biotech Pars
- Ascensia
- Platinum Equity (LifeScan)
- BAMCO Africa
- Kainico Ltd.
- Evia Medical Technologies
- Medtronic
- Agamatrix Inc.
- Bionime Corporation
- B Braun Melsungen AG
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 293 |
Published | January 2025 |
Forecast Period | 2023 - 2033 |
Estimated Market Value ( USD | $ 842.91 Million |
Forecasted Market Value ( USD | $ 2430 Million |
Compound Annual Growth Rate | 11.2% |
Regions Covered | Global |
No. of Companies Mentioned | 59 |